Octreotide acetate

Octreotide acetate Properties

Melting point	>140°C (dec.)
Boiling point	1447.2±65.0 °C(Predicted)
Density	1.39±0.1 g/cm3(Predicted)
storage temp.	-20°C
solubility	Soluble in acetic acid, DMSO, and methanol
form	Solid
pka	12.60±0.70(Predicted)
color	White to Off-White
Water Solubility	Soluble to 1.20 mg/ml in water
Stability	Hygroscopic
InChIKey	DEQANNDTNATYII-MEUDYGGUSA-N
CAS DataBase Reference	83150-76-9
FDA UNII	RWM8CCW8GP
NCI Drug Dictionary	octreotide acetate

SAFETY

Risk and Safety Statements

WGK Germany	3

Octreotide acetate price More Price(30)

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
Sigma-Aldrich	O1014	Octreotide ≥98% (HPLC)	83150-76-9	1mg	$249.6	2024-03-01	Buy
Sigma-Aldrich	O1014	Octreotide ≥98%(HPLC)	83150-76-9	500μg	$297	2024-03-01	Buy
Sigma-Aldrich	Y0002106	Octreotide impurity mixture CRS, European Pharmacopoeia (EP) Reference Standard	83150-76-9	Y0002106	$154	2023-06-20	Buy
Sigma-Aldrich	1477604	Octreotide acetate United States Pharmacopeia (USP) Reference Standard	83150-76-9	4.37mg	$1300	2021-12-16	Buy
Usbiological	256093	Octreotide Acetate	83150-76-9	1mg	$319	2021-12-16	Buy

Product number	Packaging	Price	Buy
O1014	1mg	$249.6	Buy
O1014	500μg	$297	Buy
Y0002106	Y0002106	$154	Buy
1477604	4.37mg	$1300	Buy
256093	1mg	$319	Buy

Octreotide acetate Chemical Properties,Uses,Production

Description

Octreotide is a long-acting somatostatin analog indicated for symptomatic control in acromegaly and gastroenteropancreatic tumors. Other potential uses under investigation include diabetes, psoriasis and Alzheimer's disease.

Originator

Sandoz (Switzerland)

Uses

Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. It inhibits the secretion of growth hormone, glucagon, insulin, gastrin, vasoactive intestinal peptide, secretin, motilin and pancreatic polypeptide. Octreotide acetate was uses for the treatment of severe diarrhea and flushing associated with malignant carcinoid tumors, acromegaly, and diarrhea associated with VIPoma; and, then in 2010, for the treatment of neuroendocrine tumors.

Indications

Octreotide acetate (Sandostatin) is a synthetic peptide analogue of the hormone somatostatin. Its actions include inhibition of the pituitary secretion of growth hormone and an inhibition of pancreatic islet cell secretion of insulin and glucagon. Unlike somatostatin, which has a plasma half-life of a few minutes, octreotide has a plasma elimination half-life of 1 to 2 hours. Excretion of the drug is primarily renal.

brand name

Sandostatin (Novartis).

Therapeutic Function

Antiulcer, Growth hormone inhibitor

Biological Functions

Octreotide acetate, a long-acting octapeptide analogue of somatostatin, has a half-life of approximately 100 minutes. A comparison of the primary structures of octreotide and somatostatin suggests little similarity, but from earlier work at the Salk Institute it was known that not all the residues in somatostatin were necessary to elicit its full biological activity. Other studies suggested that the essential fragment for its activity was the tetrapeptide Phe7-Trp8- Lys9-Thr10. These earlier studies helped in the design of the potent drug now known as octreotide acetate. This drug suppresses the secretion of gastroenteropancreatic peptides, such as gastrin, vasoactive intestinal peptide (VIP), insulin, and glucagon, as well as pituitary GH. Furthermore, it is more potent than natural somatostatin in inhibiting the release of glucagon, insulin, and GH.

General Description

Octreotide is a somatostatin analogue with D-Phe-Cys-Phe-D-Trp-Lys-ThrCys-Thr-OH amino acid sequence.

Biochem/physiol Actions

Octreotide is three times more potent than the native hormone in inhibiting the secretion of growth hormone glucagon and insulin in vivo. Octreotide regulates serum prolactin levels and resolves galactorrhea or (secondary) amenorrhea in acromegaly patients. Hence, this peptide can be considered as a potent therapeutic for acromegaly treatment.

Clinical Use

Octreotide acetate(83150-76-9) is used by SC injection in the palliative treatment of patients with metastatic carcinoid tumors, which are tumors of the endocrine system, GI tract, and lung (gastroenteropancreatic). Carcinoid tumors secrete increasing amounts of vasoactive substances, including histamine, serotonin, bradykinin, and prostaglandins. Octreotide acetate inhibits or suppresses the release of these vasoactive substances and, thus, is useful in treating the severe diarrhea, facial flushing, and wheezing episodes that accompany carcinoid tumors. In addition, it finds use in the palliative management of VIP-secreting tumors (VIPomas, usually pancreatic tumors). Patients with VIPomas suffer a profuse, watery diarrhea syndrome, and octreotide acetate is able to help by decreasing the release of damaging intestinal tumor cell secretions. Octreotide also helps to reduce hypokalemia by correcting electrolyte imbalances.
An excessive secretion of GH from the pituitary can cause the disorder known as acromegaly, which is characterized by a progressive enlargement of the head, face, hands, feet, and thorax. Inasmuch as octreotide acetate is able to decrease the secretion of GH from the pituitary, it is used in treating patients with acromegaly who are unresponsive to previous pituitary radiation therapy or surgery. It is used in the treatment of acromegaly, because it reduces the blood levels of both GH and insulin-like growth factor-I (IGF-I). The long-acting repository form of octreotide acetate also is used in treating acromegaly, carcinoid tumors, and VIPomas, but in monthly depot injections.
Octreotide for IV injection is used in the treatment of acute bleeding from esophageal varices. Variceal bleeding occurs in about half the patients with cirrhosis of the liver and is responsible for about one-third of deaths in these patients. Octreotide is a potent vasoconstrictor that reduces portal and collateral blood flow by constricting visceral vessels, which leads to reduced portal blood pressure and decreases the bleeding.

Side effects

Some common side effects of octreotide acetate include cardiac conduction disorder, gallbladder sludge, hyperglycemia, cardiac arrhythmia, and hypoglycemia.
Octreotide acetate may cause serious side effects, and if any of these occur, you should contact your doctor immediately. These side effects include signs of gallstones, high blood sugar, low blood sugar, and underactive thyroid. Signs of gallstones include fever, chills, nausea, vomiting, severe pain in your upper stomach spreading to your back, dark urine, clay-colored stools, or yellowing of the skin or eyes. Signs of high blood sugar include increased thirst, increased urination, dry mouth, and fruity breath odor. Signs of low blood sugar include headache, hunger, sweating, irritability, dizziness, fast heart rate, and feeling anxious or shaky. Signs of underactive thyroid include extreme tiredness, dry skin, joint pain or stiffness, muscle pain or weakness, hoarse voice, feeling more sensitive to cold temperatures, and weight gain.
https://www.drugs.com/sfx/octreotide-side-effects.html

Veterinary Drugs and Treatments

Octreotide may be useful in the adjunctive treatment of hyperinsulinemia in patients with insulinomas (especially dogs, ferrets). Response is variable, presumably dependent on whether the tumor cells have receptors for somatostatin. Octreotide may also be useful in the diagnosis and symptomatic treatment of gastrinomas in dogs or cats. It may be of use in the treatment of acute pancreatitis, but more research is needed before it can be recommended for this use in veterinary patients.

storage

Desiccate at -20°C

Mode of action

Octreotide acetate is a synthetic somatostatin analogue with similar pharmacologic effects to naturally occurring somatostatin, but with a prolonged duration of action. It inhibits pathologically increased secretion of growth hormone, thyroid stimulating hormone, and serotonin, insulin, glucagon, and other peptides produced within the gastro-entero-pancreatic endocrine system. Somatostatin is cell cycle phase-specific, mediating arrest at the G1- phase. Long acting somatostatin analogues have been shown to inhibit tumour growth.

Octreotide acetate synthesis

Synthesis of Octreotide acetate from BOC-D-Phenylalanine

Octreotide acetate Preparation Products And Raw materials

Raw materials

Octreotide N,N-Dimethylformamide Trifluoroacetic acid Amyl acetate Thioanisole

Dicyclohexylcarbodiimide N,N-Diisopropylethylamine N,N'-Diisopropylcarbodiimide Piperidine L-THREONINOL

1-Hydroxybenzotriazole

1of3

Preparation Products

Octreotide acetate Suppliers

Global( 386)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Cellmano Biotech Limited	0551-65326643 18156095617	info@cellmano.com	China	999	58
AFINE CHEMICALS LIMITED	0571-85134551	info@afinechem.com	CHINA	15377	58
Xinxiang Hongqi District Houyuan Trading Co.,Ltd	+86-0373-3695376 +86-13937349994	HYJM@houyuanjm.com	China	300	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8617865335152	Mandy@hangyubiotech.com	China	11013	58
Zhejiang Hangyu API Co., Ltd	+8617531972939	anna@api-made.com	China	2944	58
Shanghai Getian Industrial Co., LTD	+86-15373193816 +86-15373193816	mike@ge-tian.com	China	272	58
Shanghai Chinqesen Biotechnology Co., Ltd.	+86-16628886292 +86-19521323435	sales2@qschem-pharma.com	China	46	58
Shanghai Yunao International Trade Co., Ltd	+8617621705551	asdf@shanghaihg.cn	China	265	58
Henan Tengmao Chemical Technology Co. LTD	+8615238638457	salesvip2@hntmhg.com	China	415	58
Nantong Guangyuan Chemicl Co,Ltd	+undefined17712220823	admin@guyunchem.com	China	616	58

Supplier	Advantage
Cellmano Biotech Limited	58
AFINE CHEMICALS LIMITED	58
Xinxiang Hongqi District Houyuan Trading Co.,Ltd	58
Zibo Hangyu Biotechnology Development Co., Ltd	58
Zhejiang Hangyu API Co., Ltd	58
Shanghai Getian Industrial Co., LTD	58
Shanghai Chinqesen Biotechnology Co., Ltd.	58
Shanghai Yunao International Trade Co., Ltd	58
Henan Tengmao Chemical Technology Co. LTD	58
Nantong Guangyuan Chemicl Co,Ltd	58

View Lastest Price from Octreotide acetate manufacturers

Update time	Product	Price	Min. Order	Purity	Supply Ability	Manufacturer
2024-04-22	Octreotide Acetate 83150-76-9	US $0.00 / Kg/Bag	2Kg/Bag	High Density	20 tons	Sinoway Industrial co., ltd.
2024-04-22	Octreotide acetate 83150-76-9	US $30.00 / box	1box	99%	3000kg	hebei hongtan Biotechnology Co., Ltd
2024-04-16	Octreotide acetate 83150-76-9	US $0.00 / kg	1kg	99%	10000kg	Shaanxi TNJONE Pharmaceutical Co., Ltd

Octreotide Acetate
83150-76-9
US $0.00 / Kg/Bag
High Density
Sinoway Industrial co., ltd.

Octreotide acetate
83150-76-9
US $30.00 / box
99%
hebei hongtan Biotechnology Co., Ltd

Octreotide acetate
83150-76-9
US $0.00 / kg
99%
Shaanxi TNJONE Pharmaceutical Co., Ltd

Octreotide acetate Spectrum

Octreotide acetate(83150-76-9)MS

83150-76-9(Octreotide acetate)Related Search:

Glucagon Oxytocin Goserelin acetate Butyl acetate Cellulose acetate

Benzyl acetate Vinyl acetate Ethyl acetate Sodium acetate Ammonium acetate

Leuprorelin Exenatide acetate HOE-140 ACETATE Octreotide

DOTA-(Tyr3)-Octreotate DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Octreotide acetate

1of4

DARAMONOL ctreotide Ocetreotide, Acetate L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl-, cyclic (2?7)-disulfide OXTREOTIDE [R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide Octreotide acetate L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*)) H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond) [R-(R^<*>^，R^<*>^)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxyl-1-(hydroxyl-methyl)propyl]-L-cysteinarnide cydic(2→7)-disulfide Longastatin D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-N-[(1R,2R)-1-(Hydroxymethyl)-2-hydroxypropyl]-NH2 D-Phe-L-Cys(1)-L-Phe-D-Trp-L-Lys-L-Thr-L-Cys(1)-N-[(1R,2R)-2-Hydroxy-1-(hydroxymethyl)propyl]-NH2 Octreotode Acetate OCTREOTIDE ACETATE (GMP) APIOC OCTREOTIDE ACETATE Octreotide Hydrochloride (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4- GMP(CFDA) 32) Octreotide Acetate Octreotide acetate USP/EP/BP Octreotide Acetate（b） 83150-76-9 C49H66N10O10S22C2H4O C48H66N10O9S2 C49H66N10O10S22C2H4O2 101924 Inhibitors API Peptide